The Enterprise Value as of June 2026 (TTM) for Entero Therapeutics, Inc. (ENTO) is 19.92M

According to Entero Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.92M. This represents a change of 138.16% compared to the average of 8.37M of the last 4 quarters.

Entero Therapeutics, Inc. (ENTO) Historical Enterprise Value (quarterly & annually)

How has ENTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Entero Therapeutics, Inc. over the last ten years is 47.37M. The current 19.92M Enterprise Value has changed 4.11% with respect to the historical average. Over the past ten years (40 quarters), ENTO's Enterprise Value was at its highest in in the March 2021 quarter at 210.75M. The Enterprise Value was at its lowest in in the December 2023 quarter at 1.62M.

Entero Therapeutics, Inc. (ENTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Entero Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Entero Therapeutics, Inc. (ENTO) Average Enterprise Value

How has ENTO Enterprise Value performed in the past?

The current Enterprise Value of Entero Therapeutics, Inc. (ENTO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Entero Therapeutics, Inc. (ENTO) Enterprise Value vs. Peers

How is ENTO’s Enterprise Value compared to its peers?

Entero Therapeutics, Inc.’s Enterprise Value is greater than Curis, Inc. (-8118049.00), greater than Processa Pharmaceuticals, Inc. (3.23M), greater than BriaCell Therapeutics Corp. (-1763599.79), less than Palisade Bio, Inc. (164.19M), greater than Citius Pharmaceuticals, Inc. (2.25M), less than Leap Therapeutics, Inc. (30.18M), greater than Aspire Biopharma Holdings, Inc. (-4785565.00), greater than Athira Pharma, Inc. (1.07M), greater than Cingulate Inc. (8.89M), less than Allarity Therapeutics, Inc. (24.44M),

Build a custom stock screener for Entero Therapeutics, Inc. (ENTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entero Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Entero Therapeutics, Inc. (ENTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Entero Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.